Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$10,212,557
+$1,417,044 QoQ
Shares Held
40,584
+0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#909
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $46,810,911 across 13 Drug Manufacturers - General names. ABBV ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,775 | $12,923,859 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
40,584 | $10,212,557 | |
| 3 | JNJ |
Johnson & Johnson
|
22,980 | $5,836,230 | |
| 4 | AMGN |
Amgen Inc
|
14,031 | $5,080,905 | |
| 5 | NVO |
Novo Nordisk A S
|
66,135 | $3,170,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,666 | $2,655,581 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
35,462 | $2,043,320 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,955 | $1,636,734 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,212,557 | 40,584 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $8,795,513 | 40,441 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $9,126,119 | 39,941 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,055,529 | 39,110 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $7,577,750 | 40,824 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $8,054,786 | 38,444 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $4,765,203 | 26,816 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $6,213,905 | 31,466 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $5,643,008 | 32,900 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $5,659,485 | 31,079 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $5,189,325 | 33,486 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $5,039,718 | 33,810 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $4,260,027 | 31,619 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,804,686 | 30,148 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,814,038 | 29,788 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,823,777 | 28,491 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,244,982 | 27,716 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,687,086 | 28,913 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,387,366 | 32,403 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,483,985 | 32,298 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $3,301,365 | 29,309 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,998,667 | 27,709 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,836,581 | 26,473 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,265,515 | 25,865 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,392,057 | 24,364 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,691,341 | 22,199 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||